Spikevax (Note 2) (bivalent, Original/Omicron BA.1) Partial Change Approval
Coronavirus Modified Uridine RNA Vaccine (SARS-CoV-2) (active ingredients: elasomeran and imelasomeran)
Approval Information
Brand NameSpikevax (Note 2)
(bivalent, Original/Omicron BA.1)
Partial Change Approval
Generic NameCoronavirus Modified Uridine RNA Vaccine (SARS-CoV-2)
(active ingredients: elasomeran and imelasomeran)
ApprovedSeptember 2022
TypeInitial Approval
Want structured data, translation summaries & alerts?
PharmaLens is building the most comprehensive English-language PMDA intelligence platform. Join the waitlist for early access.
Join the WaitlistSource: PMDA Website. Review reports are provided under Japan's Public Data License v1.0. Translations and structured data by PharmaLens are unofficial and for reference only.